Wave Life Sciences Reports Second Quarter 2021 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
WAVE Life Sciences (WVE) Misses Q2 EPS by 14c
August 5, 2021 7:58 AM EDTWAVE Life Sciences (NASDAQ: WVE) reported Q2 EPS of ($0.78), $0.14 worse than the analyst estimate of ($0.64). Revenue for the quarter came in at $2.78 million versus the consensus estimate of $9.79 million.
Since the start of the second quarter, Wave has achieved two significant milestones: the intrathecal dosing of patients with an oligonucleotide containing PN chemistry and preclinical proof-of-concept protein... More
